The Vioxx Pharmaceutical Scandal: Peterson v Merke, Sharpe & Dohme (Aust) Pty Ltd (2010) 184 FCR 1
In early March 2010, Federal Court Justice Jessup in Peterson v Merke Sharpe & Dohme (Aust) Pty Ltd (2010) 184 FCR 1 ruled that Merke Sharpe & Dohme Pty Ltd had produced a defective product contrary to the Trade Practices Act 1974 (Cth), the anti-arthritic drug Vioxx. Promoted as relieving arthritic pain without the side effect of gastric ulceration, the drug also doubled the risk of heart attack in those prescribed it. The court also heard that the manufacturing company had engaged in...[Show more]
|Collections||ANU Research Publications|
|Source:||Journal of Law and Medicine|
|01_Faunce_The_Vioxx_Pharmaceutical_2010.pdf||89.28 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.